TB Biosciences
Bethlehem · Founded 2013
About TB Biosciences
TB Biosciences, Inc. is an early stage development medical diagnostics company founded in June 2013 to develop a rapid point-of-care tuberculosis test that meets performance standards around the world. The goal of TB Biosciences is to commercialize a simple to operate and use tuberculosis test that replaces the 125 year old sputum smear test. The Company is using an array of patented peptides developed and exclusively licensed from the NYU School of Medicine.
Company Facts
- Founded: 2013
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2013)
- Website: http://tbbiosciences.com
- Phone: +1 212-995-3250
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/tb-biosciences-990858 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.